jump to content jump to footer
- 37 minute(s)

Clinical trial excellence for routine covid-19 assessment

Mint Medical is on the front lines in the fight against COVID-19, proving that radiology can act as a role model for gathering evidence by utilizing structured data.
 
In this webcast, Prof. Dr. Maria-Katharina Ganten and Gabriel Salg highlight the urgent need for structured data collection, as well as the importance of data quality, integrity, and traceability. The hosts discuss how to support trial compatible data acquisition in routine work by example of a European multicenter project.
 
Prof. Ganten and Mr. Salg also provide a look to the future in which radiology has the opportunity to set standards for new research strategies, not only concerning COVID studies but rather for any disease or treatment.

Radiologist reviewing a glioma MRI case in mint Lesion, with AI-based brain tumor segmentation from Snke (in development)
Consistent Glioma MRI Reporting with mint Lesion
In neuro-oncology, imaging assessments directly shape treatment decisions. For example, under RANO 2.0, whether a follow-up MRI is classified as…
Read more
Portrait of Ralf Heyder, head of the NUM Coordination Office at Charité, interviewed at the RACOON Research Days in Tübingen
Ralf Heyder, head of the NUM Coordination Office at Charité, interviewed at the RACOON Research Days in Tübingen
RACOON in the Network University Medicine – Ralf Heyder on collaborative imaging research
How Germany’s university hospitals built a shared platform for radiological imaging data, and what comes next In early October 2026, representatives…
Read more
Radiologist reviewing whole-body MRI images with AI-supported tumor burden quantification for bone metastases and multiple myeloma using mint Lesion.
Mint Medical has integrated an AI algorithm developed by The Institute of Cancer Research and The Royal Marsden into mint Lesion. The solution supports bone disease assessment and treatment response evaluation in advanced prostate cancer and multiple myeloma.
The ICR and The Royal Marsden work with Mint Medical to integrate AI-powered software into cancer treatment
The Institute of Cancer Research (ICR), London, and The Royal Marsden NHS Foundation Trust have announced a new licensing agreement with MedTech…
Read more
scroll-top